Takeda Pharmaceutical (TAK) Treasury Shares (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Treasury Shares of -$297.6 million for Q2 2026, up 65.3% year-over-year from -$180.1 million in Q2 2025, and up 4.99% quarter-over-quarter from -$313.3 million in Q1 2026.
Takeda Pharmaceutical (TAK) Treasury Shares (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at -$297.6 million for Q2 2026.
- In Q2 2026, Treasury Shares rose 65.3% year-over-year to -$297.6 million; the TTM figure through Jun 2026 stood at -$297.6 million (up 65.3% YoY), while the FY2026 annual figure was -$342.8 million, down 169.8% from the prior year.
- Treasury Shares for Q2 2026 stood at -$297.6 million, up from -$313.3 million in the prior quarter.
- The five-year high for Treasury Shares was $274426.1 in Q1 2022, with the low at $92886.0 in Q1 2019.
- The 5-year median for Treasury Shares is $170904.3 (2020), against an average of $174247.0.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 96.44% in 2024, then tumbled 2675.72% in 2025.
- Takeda Pharmaceutical's Treasury Shares stood at -$710.1 million in 2022, then soared by 51.17% to -$346.7 million in 2023, then soared by 52.89% to -$163.4 million in 2024, then tumbled by 105.26% to -$335.3 million in 2025, then gained by 11.24% to -$297.6 million in 2026.
- Business Quant data shows TAK's Treasury Shares at -$297.6 million in Q2 2026, -$313.3 million in Q1 2026, and -$335.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -297.63 Mn |
| Jun 30, 2026 | -297.63 Mn |
| Mar 31, 2026 | -313.27 Mn |
| Mar 31, 2026 | -313.27 Mn |
| Dec 31, 2025 | -335.31 Mn |
| Dec 31, 2025 | -335.31 Mn |
| Sep 30, 2025 | -350.22 Mn |
| Sep 30, 2025 | -350.22 Mn |
| Jun 30, 2025 | -857.83 Mn |
| Jun 30, 2025 | -857.83 Mn |
| Mar 31, 2025 | 490.38 Mn |
| Mar 31, 2025 | 490.38 Mn |
| Dec 31, 2024 | -163.36 Mn |
| Dec 31, 2024 | -163.36 Mn |
| Sep 30, 2024 | -12.62 Mn |
| Sep 30, 2024 | -12.62 Mn |
| Jun 30, 2024 | -326.96 Mn |
| Jun 30, 2024 | -326.96 Mn |
| Mar 31, 2024 | 345.89 Mn |
| Mar 31, 2024 | 345.89 Mn |